| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.04 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |